Myocardial protection by remote ischaemic pre-conditioning is abolished in sulphonylurea-treated diabetics undergoing coronary revascularisation
- 18 February 2014
- journal article
- research article
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 58 (4) , 453-462
Abstract
Remote ischaemic pre-conditioning attenuates myocardial injury. Because sulphonylurea drugs interfere with ischaemic and anaesthetic pre-conditioning, we assessed whether remote ischaemic pre-conditioning effects are altered in sulphonylurea-treated diabetics. Using the database of our ongoing randomised, placebo-controlled study (ClinicalTrials.gov NCT01406678), we assessed the troponin I concentration area under curve (measurements: baseline, 1, 6, 12, 24, 48, and 72 h post-operatively) in sulphonylurea-treated diabetics (n = 27) and non-diabetics (n = 230) without and with remote ischaemic pre-conditioning (three 5-min periods of left upper arm ischaemia with 5-min reperfusion each) during isoflurane anaesthesia before two- to three-vessel coronary artery surgery. Remote ischaemic pre-conditioning in non-diabetic patients evoked a 41% decrease in the troponin I concentration area under curve (514 ng/ml × 72 h ± 600 vs. 302 ± 190, P = 0.001) but no change (404 ng/ml × 72 h ± 224 vs. 471 ± 383, P = 0.62) in sulphonylurea-treated diabetics. There was no significant correlation between the troponin I concentration area under curve and arterial glucose concentrations, and the latter was not an independent confounder. Cardioprotection by remote ischaemic pre-conditioning during isoflurane anaesthesia is abolished in sulphonylurea-treated diabetics.Keywords
This publication has 37 references indexed in Scilit:
- Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trialThe Lancet, 2013
- Remote Ischemic Preconditioning Improves Outcome at 6 Years After Elective Percutaneous Coronary InterventionCirculation: Cardiovascular Interventions, 2013
- Cardioprotection in the aging, diabetic heart: the loss of protective Akt signallingCardiovascular Research, 2013
- Chronic Metformin Associated Cardioprotection Against Infarction: Not Just a Glucose Lowering PhenomenonCardiovascular Drugs and Therapy, 2012
- Efficacy of Cardioprotective ‘Conditioning’ Strategies in Aging and Diabetic CohortsDrugs & Aging, 2011
- Is impairment of ischaemic preconditioning by sulfonylurea drugs clinically important?Heart, 2003
- Activation of ATP-dependent potassium channels is a trigger but not a mediator of ischaemic preconditioning in pigsBritish Journal of Pharmacology, 2003
- Insulin therapy as an adjunct toreperfusion after acute coronary ischemiaJACC, 2003
- Glimepiride block of cloned β‐cell, cardiac and smooth muscle KATP channelsBritish Journal of Pharmacology, 2001
- Glyburide, a KATP Channel Antagonist, Attenuates the Cardioprotective Effects of Isoflurane in Stunned MyocardiumAnesthesia & Analgesia, 1996